Onclive® Announces State of the Science Summit™: Genitourinary Cancers

CRANBURY, N.J.--()--Onclive® announces its latest State of the Science Summit™ focusing on genitourinary cancers on May 18, 2017, at InterContinental Cleveland in Cleveland. This half- day event, which includes dinner and a networking reception, will be chaired by Brian Rini, M.D., associate professor of medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland. Dr. Rini will be joined by the following oncology experts, who will share their professional expertise:

  • Jorge Garcia, M.D., serves as an assistant professor of medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Dr. Garcia primarily focuses on genitourinary malignancies and is the current director of advanced prostate cancer research program at the Cleveland Clinic.
  • Moshe Ornstein, M.D., is a hematology/ oncology fellow at Cleveland Clinic Taussig Cancer Institute. Dr. Ornstein’s researches on kidney and prostate cancer and has received Conquer Cancer Foundation of ASCO Merit Award acknowledging his research.
  • Andrew Stephenson, M.D., is the director for the Center of Urologic Oncology at Cleveland Clinic’s Glickman Urology and Kidney Institute. Dr. Stephenson subspecializes in surgical oncology.

This State of the Science Summit™ will focus on pressing issues faced by oncologists and patients alike. Primary topics of discussion at the event will include the evolving landscape of adjuvant therapy in resected localized renal cell carcinoma, early prostate cancer surveillance strategies, immunotherapy for bladder cancer and therapies for renal cell cancer. The event will conclude with a panel case discussions, which will provide the attendees with an opportunity to share and discuss patient cases.

For more information and to register, please visit www.onclive.com/meetings/soss.

About OncLive®

A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can use to help provide the best patient care. OncLive® is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management® and more. Michael J. Hennessy Associates, Inc. is a full-service health care communications company offering education, research, medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.

Contacts

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

Release Summary

Onclive® State of the Science Summit™ coming to Cleveland.

#Hashtags

Contacts

OncLive® Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com